Search

everythinglearnresearchcommunity

for

Search:↓

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

MK-386 reduces sebum DHT levels.

TS-SCLF from fermented Schisandra chinensis may promote hair growth and improve hair quality.

The N-K GM Series offers treatments for full hair restoration and permanent hair removal, claiming 100% effectiveness without side effects.

The N-K GM Series offers treatments for full hair restoration and permanent hair removal, claiming 100% effectiveness without side effects.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

MG53 helps reduce skin damage caused by nitrogen mustard.

Type 3 acromegaly patients have more health issues and higher death risk.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Researchers created a new mouse model, G4, that mimics human PCOS symptoms and links the condition to a specific gene.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

A hormone affects hair growth, certain molecules may prevent skin damage, a skin disease is linked to immune cells, glycerol helps skin hydration, and psoriasis treatment trials need improvement.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

A 4kb fragment of the desmocollin 3 promoter targets gene expression to specific skin and hair follicle areas.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.